Q4 2025 Management View CEO Lishan Aklog reported that "our EsoGuard test volume in the fourth quarter was 3,664. That exceeds our target range that we've articulated regularly of approximately 2,500 ...
Fulgent’s arsenal has expanded to include a monkeypox test. Just as its record testing run for Covid-19 appears to be tapering off, Temple City-based Fulgent Genetics Inc. has added testing for ...
New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that COVID-19 RT-PCR testing volume has increased in 2022 ...
Laboratory Corporation of America Holdingsor LabCorp LH is gaining from an ongoing rebound in the base business across both operating segments. A strong solvency position is an added upside. However, ...
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund ...
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results